The genetics of cancer-a 3d model

Nature Genetics

Volumn 21, Issue 1S, 1999, Pages 41-

  Cole, Kristina A ^a,b   Krizman, David B ^a   Emmert Buck, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; DNA FINGERPRINTING; GENE SEQUENCE; GENE TECHNOLOGY; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING;

DATABASES, FACTUAL; GENE EXPRESSION; GENOME, HUMAN; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; SPECIMEN HANDLING;

EID: 84984934707     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/4466     Document Type: Article

References (47)

1. Nowak, R. Entering the postgenome era. Science 270, 368-371 (1995).
2. Abbott, A. DNA chips intensify the sequence search. Nature 379, 392 (1996).
3. Schena, M. et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-469 (1995).
4. Velculescu, V. et al. Serial analysis of gene expression. Science 270, 484-487 (1995).
5. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
6. Schena, M. et al. Microarrays: Biotechnology’s discovery platform for functional genomics. TrendsBiotechnol. 16, 301-306 (1998).
7. Ramsay, G. DNA chips: State of the art. Nature Biotechnol. 16, 40-44 (1998).
8. Bowtell, D.L. Options available-from start to finish-for obtaining expression data by microarray. Nature Genet. 21, 25-32 (1999).
9. Strausberg, R.L., Dahl C.A. & Klausner R.D. New opportunities for uncovering the molecular basis of cancer. Nature Genet. 16, 415-416 (1997).
10. Murphy, G.P. et al. Histopathology of localized prostate cancer. Consensus conference on diagnosis and prognostic parameters in localized prostate cancer. Scand. J. Urol. Nephrol. Suppl. 162, 7-42 (1994).
11. Epstein, J.I. Pathologic evaluation of prostatic carcinoma: Critical information for the oncologist. Oncology 10, 527-534 (1996).
12. Bostwick, D.G. & Montironi R. Evaluating radical prostatectomy specimens: Therapeutic and prognostic importance. VirchowsArch. 430, 1-16 (1997).
13. Small, E.J. Update on the diagnosis and treatment of prostate cancer. Curr. Opin. Oncol. 10, 244-252 (1998).
14. Pettaway, C.A. Prognostic markers in clinically localized prostate cancer. Tech. Urol. 4, 35-42 (1998).
15. Klimecki, W.T., Futscher, B.W. & Dalton, W.S. Effects of ethanol and paraformaldehyde on RNA yield and quality. Biotechniques 16, 1021-1023 (1994).
16. Deng, G., Lu, Y., Zlotnikov, G., Thor, A.D. & Smith, H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 20, 2057-2059 (1996).
17. Chuaqui, R.F. et al. PB39: Identification of a novel gene up-regulated in clinically aggressive human prostate cancer. Urology 50, 302-307 (1997).
18. Zhuang, Z. et al. Barrett’s esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res. 56, 1961-1964 (1996).
19. Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Amer. Med. A 273, 1908-1910 (1995).
20. Bostwick, D. & Brawer, M.K. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59, 788-794 (1987).
21. Bostwick, D.G. Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur. Urol. 30, 145-152 (1996).
22. Isaacs, W. et al. genetic alterations in prostate cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 653-659 (1994).
23. Latil, A. & Lidereau, R. Genetic aspects of prostate cancer. Virchows Arch. 432, 389-406 (1998).
24. Dong J.T., Isaacs, W.B. & Isaacs, J.T. Molecular advances in prostate cancer. Curr. Opin. Oncol. 9, 101-107 (1997).
25. Lalani, E.N., Stubbs, A. & Stamp, G.W. Prostate cancer; the interface between pathology and basic scientific research. Semin. Cancer Biol. 8, 53-59 (1997).
26. Hayward, S.W., Grossfeld, G.D., Tlsty, T.D. & Cunha G.R. Genetic and epigenetic influences in prostatic carcinogenesis. Int. J. Oncol. 13, 35-47 (1998).
27. MacDougall, J. & Matrisian, L.M. Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14, 351-362 (1995).
28. McCoy, K. et al. An acid protease secreted by transformed cells interferes with antigen processing. J. Cell Biol. 106, 1879-1884 (1988).
29. Emmert-Buck, M.R. et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia (PIN). Cancer Res. 55, 2959-2962 (1995).
30. Bostwick D.G. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 78, 330-336 (1996).
31. Eberwine, J. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. Biotechniques 20, 584-591 (1996).
32. Bassett, D.E. Jr, Eisen, M.B. & Boguski, M.S. Gene expression informatics-it’s all in your mine. Nature Genet. 21, 51-55 (1999).
33. Emmert-Buck, M. etal. Increased gelatinase A and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145, 1285-1290 (1994).
34. Giometti, C.S., Williams, K. & Tollaksen, S.L. A two-dimensional electrophoresis database of human breast epithelial cell proteins. Electrophoresis 16, 1187-1189 (1997).
35. Ching J., Voivodov, K.I. & Hutchens, T.W. Polymers as surface-based tethers with photolytic triggers enabling laser-induced release/desorption of covalently bound molecules. Bioconjug. Chem. 7, 525-528 (1996).
36. Kuwata, H. etal. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem. Biophys. Res. Commun. 245, 764-773 (1998).
37. Suzuki, H. et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58, 204-209 (1998).
38. Wiltshire, R. et al. Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissection and comparative genomic hybridization. CancerRes. 55, 3954-3957 (1995).
39. Vocke, C. et al. Analysis of 99 microdissected prostate carcinomas reveals high frequency of allelic loss on chromosome 8p12-21. Cancer Res. 56, 2411-2416 (1996).
40. Bova, G.S. & Isaacs, W.B. Review of allelic loss and gain in prostate cancer. World J. Urol. 14, 338-346 (1996).
41. Emmert-Buck, M.R. et al. Laser capture microdissection. Science 274, 998-1001 (1996).
42. Bonner, R.F. et al. Laser capture microdissection: Molecular analysis of tissue. Science 278, 1481-1483 (1997).
43. Krizman, D.B. et al. Construction of a representative cDNA library from prostatic intraepithelial neoplasia (PIN). CancerRes. 56, 5380-5383 (1996).
44. Levedakou, E.N. et al. Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: Cloning and characterization of their expression pattern. Oncogene 9, 1977-1988 (1994).
45. Kallajokl, M., Alanen, K.A., Nevalainen, M. & Nevalainen, T.J. Group II phsopholipase A2 in human male reproductive organs and genital tumors. Prostate 35, 263-272 (1998).
46. Imajoh-Ohmi, S. et al. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cell. Biochem. Biophys. Res. Commun. 217, 1070-1077 (1995).
47. Taylor, I.C. et al. Mouse mammary tumors express elevated levels of RNA encoding the murine homology of SKY, a putative tyrosine kinase. J. Biol. Chem. 270, 6872-6880 (1995).